D
Donald Heck
Researcher at Novant Health
Publications - 11
Citations - 726
Donald Heck is an academic researcher from Novant Health. The author has contributed to research in topics: Stroke & Asymptomatic. The author has an hindex of 7, co-authored 11 publications receiving 570 citations. Previous affiliations of Donald Heck include University of Miami.
Papers
More filters
Journal ArticleDOI
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis
Thomas G. Brott,George Howard,Gary S. Roubin,James F. Meschia,Ariane Mackey,William H. Brooks,Wesley S. Moore,Michael D. Hill,Vito A. Mantese,Wayne M. Clark,Carlos H. Timaran,Donald Heck,Pierre P. Leimgruber,Alice J. Sheffet,Virginia J. Howard,Seemant Chaturvedi,Brajesh K. Lal,Jenifer H. Voeks,Robert W. Hobson +18 more
TL;DR: Over 10 years of follow-up, there did not find a significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke.
Journal ArticleDOI
Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggressive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage
Donald Heck,Morry D Brown +1 more
TL;DR: Primary stenting of the extracranial carotid artery combined with intracranial mechanical thrombectomy can be an effective treatment for tandem occlusions, can be performed with a high rate of technical success, and can achieve good clinical outcomes in selected patients, however, the incidence of SICH may be higher than in other patient populations and may be associated with the use of abciximab and advanced patient age.
Journal ArticleDOI
Mediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
Jenifer H. Voeks,George Howard,Gary S. Roubin,Richard I. Farb,Donald Heck,William Logan,Mary E Longbottom,Alice J. Sheffet,James F. Meschia,Thomas G. Brott +9 more
TL;DR: Plaque length seems to be in the pathway between older age and higher risk of S+D among carotid artery stenting–treated patients, but it mediated only 8% of the age effect excess risk of carotids stenting in CREST.
Journal ArticleDOI
Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.
Tanya N. Turan,Jenifer H. Voeks,Marc I. Chimowitz,Ana Roldan,Todd LeMatty,William Haley,Maria F. Lopes-Virella,Seemant Chaturvedi,Michael R. Jones,Donald Heck,George Howard,Brajesh K. Lal,James F. Meschia,Thomas G. Brott +13 more
TL;DR: The rigorous multimodal approach to intensive stroke risk factor management in CREST2 has resulted in significant improvements in risk factor control that will enable a comparison of cutting-edge medical care to revascularization in patients with asymptomatic carotid stenosis.
Journal ArticleDOI
Quality Assurance for Carotid Stenting in the CREST-2 Registry
Brajesh K. Lal,Gary S. Roubin,Kenneth Rosenfield,Donald Heck,Michael R. Jones,Brian T. Jankowitz,Tudor G Jovin,Seemant Chaturvedi,Guilherme Dabus,Christopher J. White,William A. Gray,Jon S. Matsumura,Barry T. Katzen,L. Nelson Hopkins,Minerva Mayorga-Carlin,John D. Sorkin,George Howard,James F. Meschia,Thomas G. Brott +18 more
TL;DR: This study reports periprocedural outcomes in a cohort of carotid artery stenting (CAS) performed for asymptomatic and symptomaticCarotid stenosis, the first national registry for CAS cosponsored by federal and industry partners.